» Articles » PMID: 37150253

Immunoregulation in Cancer-associated Cachexia

Overview
Journal J Adv Res
Date 2023 May 7
PMID 37150253
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cancer-associated cachexia is a multi-organ disorder associated with progressive weight loss due to a variable combination of anorexia, systemic inflammation and excessive energy wasting. Considering the importance of immunoregulation in cachexia, it still lacks a complete understanding of the immunological mechanisms in cachectic progression.

Aim Of Review: Our aim here is to describe the complex immunoregulatory system in cachexia. We summarize the effects and translational potential of the immune system on the development of cancer-associated cachexia and we attempt to conclude with thoughts on precise and integrated therapeutic strategies under the complex immunological context of cachexia.

Key Scientific Concepts Of Review: This review is focused on three main key concepts. First, we highlight the inflammatory factors and additional mediators that have been identified to modulate this syndrome. Second, we decipher the potential role of immune checkpoints in tissue wasting. Third, we discuss the multilayered insights in cachexia through the immunometabolic axis, immune-gut axis and immune-nerve axis.

Citing Articles

L-shaped association of body mass index with prognosis in individuals with sepsis: a multicenter cohort study.

Cui K, Teng X, Liu W, Zhao X, Xu S, Bai L Diabetol Metab Syndr. 2025; 17(1):43.

PMID: 39901292 PMC: 11789304. DOI: 10.1186/s13098-025-01607-w.


Association of CVAI, LAP and SMI with risk of haematological toxicity after immunochemotherapy in patients with DLBCL: a retrospective study.

Liao C, Lai H, Tu Y, He L, Lin C, Tu H Ther Adv Hematol. 2025; 16:20406207251314631.

PMID: 39897506 PMC: 11783497. DOI: 10.1177/20406207251314631.


Systemic Metabolic and Volumetric Assessment via Whole-Body [F]FDG-PET/CT: Pancreas Size Predicts Cachexia in Head and Neck Squamous Cell Carcinoma.

Yu J, Spielvogel C, Haberl D, Jiang Z, Ozer O, Pusitz S Cancers (Basel). 2024; 16(19).

PMID: 39409971 PMC: 11475137. DOI: 10.3390/cancers16193352.


The Role of Non-Coding RNAs in Regulating Cachexia Muscle Atrophy.

Chen G, Zou J, He Q, Xia S, Xiao Q, Du R Cells. 2024; 13(19.

PMID: 39404384 PMC: 11482569. DOI: 10.3390/cells13191620.


Effects of Reflexology on Anorexia and Sleep Quality in Patients Undergoing Chemotherapy: A Randomized Clinical Trial.

Akbari M, Golitaleb M, Farahani M, Nikbakht D, Shahrodi M, Davodabady F Iran J Nurs Midwifery Res. 2024; 29(3):337-342.

PMID: 39100404 PMC: 11296600. DOI: 10.4103/ijnmr.ijnmr_62_23.


References
1.
Li C, Wu Q, Li Z, Wang Z, Tu Y, Chen C . Exosomal microRNAs in cancer-related sarcopenia: Tumor-derived exosomal microRNAs in muscle atrophy. Exp Biol Med (Maywood). 2021; 246(10):1156-1166. PMC: 8142113. DOI: 10.1177/1535370221990322. View

2.
Verzola D, Bonanni A, Sofia A, Montecucco F, DAmato E, Cademartori V . Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease. J Cachexia Sarcopenia Muscle. 2016; 8(1):131-144. PMC: 5326826. DOI: 10.1002/jcsm.12129. View

3.
Burfeind K, Zhu X, Norgard M, Levasseur P, Huisman C, Michaelis K . Microglia in the hypothalamus respond to tumor-derived factors and are protective against cachexia during pancreatic cancer. Glia. 2020; 68(7):1479-1494. PMC: 7205589. DOI: 10.1002/glia.23796. View

4.
Clement K, van den Akker E, Argente J, Bahm A, Chung W, Connors H . Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diabetes Endocrinol. 2020; 8(12):960-970. DOI: 10.1016/S2213-8587(20)30364-8. View

5.
Kir S, White J, Kleiner S, Kazak L, Cohen P, Baracos V . Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature. 2014; 513(7516):100-4. PMC: 4224962. DOI: 10.1038/nature13528. View